Articles

As a food labeling system, a color-coded “traffic light” system is superior to currently used percentage daily intake systems in helping consumers identify healthy foods, according to a new study.

Pharmacists show why they need to be part of the “Diabetes Team” and the Ten City Challenge diabetes education program shows that they can also reduce costs ($1,079/patient) as well as reducing A1c levels along with cholesterol and blood pressure.

Children are eating themselves into an early grave with hundreds of thousands of primary school pupils already suffering from chronic disease, a study has found.

Approximately 6.3 million adults – or one-fourth of the people in the U.S. with diabetes mellitus – are unaware they have the disease, and this undiagnosed population accounts for an estimated $18 billion in health care costs each year.

Patients with extreme obesity achieved 8.3% weight loss after 2 years of intensive medical intervention compared with 0.5% in a control group, according to new research

ROADMAP is the first-ever, large-scale clinical trial, being conducted in 19 European countries to evaluate whether the angiotensin II receptor blocker (ARB) olmesartan medoxomil can prevent the onset of microalbuminuria in patients with Type 2 diabetes (T2DM).

To compare injects by syringe and using an insulin pump a randomized open parallel multicenter study was done. The results showed

Patients suffering from post-traumatic peripheral nerve pain treated with Lyrica® (pregabalin) capsules CV experienced significantly reduced pain compared to those taking placebo, according to new data.

Novo Nordisk announces that the Committee for Medicinal Products for Human Use (CHMP), under the European Medicines Agency (EMEA) adopted a positive opinion, recommending marketing authorization, for Victoza® for the treatment of Type 2 diabetes.

An analysis of previous studies indicates that among patients with peripheral artery disease, aspirin use is associated with a statistically nonsignificant decrease in the risk of a group of combined cardiovascular events (nonfatal heart attack, nonfatal stroke, and cardiovascular death), butis associated with a significant reduction in the risk of …